Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020720

Expand all

REZULIN (TROGLITAZONE)
200MG Marketing Status: Discontinued

Active Ingredient: TROGLITAZONE
Proprietary Name: REZULIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020720
Product Number: 001
Approval Date: Jan 29, 1997
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

REZULIN (TROGLITAZONE)
300MG Marketing Status: Discontinued

Active Ingredient: TROGLITAZONE
Proprietary Name: REZULIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020720
Product Number: 003
Approval Date: Aug 4, 1997
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

REZULIN (TROGLITAZONE)
400MG Marketing Status: Discontinued

Active Ingredient: TROGLITAZONE
Proprietary Name: REZULIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020720
Product Number: 002
Approval Date: Jan 29, 1997
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English